The Valley Desk

ReviewAdvances in therapyPublished

Transitioning Prostacyclin Pathway Agents to Oral Selexipag in Patients with Pulmonary Arterial Hypertension: A Systematic Literature Review

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Review
Venue
Advances in therapy
Published
Subject terms
Humans; Acetamides; Pyrazines; Epoprostenol; Antihypertensive Agents; Administration, Oral; Pulmonary Arterial Hypertension; Systematic Literature Review; Selexipag; Prostacyclin Pathway Agents; Transition Protocol
PubMed ID
41678138
PubMed Central ID
PMC13065581
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal